Prevalence of conventional risk factors in. patients with coronary heart disease

被引:1042
作者
Khot, UN
Khot, MB
Bajzer, CT
Sapp, SK
Ohman, EM
Brener, SJ
Ellis, SG
Lincoff, AM
Topol, EJ
机构
[1] Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA
[2] Univ N Carolina, Sch Med, Dept Med, Div Cardiol, Chapel Hill, NC USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2003年 / 290卷 / 07期
关键词
D O I
10.1001/jama.290.7.898
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context It is commonly suggested that more than 50% of patients with coronary heart disease (CHD) lack any of the conventional risk factors (cigarette smoking, diabetes, hyperlipidemia, and hypertension). This claim implies that other factors play a significant role in CHID and has led to considerable interest in nontraditional risk factors and genetic causes of CHD. Objective To determine the prevalence of the 4 conventional risk factors among patients with CHD. Design, Setting, and Patients In 2002-2003, we analyzed data for 122458 patients enrolled in 14 international randomized clinical trials of CHD conducted during the prior decade. Patients included 76716 with ST-elevation myocardial infarction, 35527 with unstable angina/non-ST-elevation myocardial infarction, and 10215 undergoing percutaneous coronary intervention. Main Outcome Measures Prevalence of each conventional risk factor and number of conventional risk factors present among patients with CHID, compared between men and women and by age at trial entry. Results Among patients with CHD, at least 1 of the 4 conventional risk factors was present in 84.6% of women and 80.6% of men. In younger patients (men : :55 years and women : 65 years) and most patients presenting either with unstable angina or for percutaneous coronary intervention, only 10% to 15% of patients lacked any of the 4 conventional risk factors. This pattern was largely independent of sex, geographic region, trial entry criteria, or prior CHD. Premature CHD was related to cigarette smoking in men and cigarette smoking and diabetes in women. Smoking decreased the age at the time of CHD event (at trial entry) by nearly 1 decade in all risk factor combinations. Conclusions In direct contrast with conventional,thinking, 80% to 90% of patients with CHID have conventional risk factors. Although research on nontraditional risk factors and genetic causes of heart disease is important, clinical medicine, public health policies, and research efforts should place significant emphasis on the 4 conventional risk factors and the lifestyle behaviors causing them to reduce the epidemic of CHD.
引用
收藏
页码:898 / 904
页数:7
相关论文
共 55 条
  • [1] 41-MONTH FOLLOW-UP OF RISK-FACTORS CORRELATED WITH NEW CORONARY EVENTS IN 708 ELDERLY PATIENTS
    ARONOW, WS
    HERZIG, AH
    ETIENNE, F
    DALBA, P
    RONQUILLO, J
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1989, 37 (06) : 501 - 506
  • [2] WHY IS DIABETES-MELLITUS A STRONGER RISK FACTOR FOR FATAL ISCHEMIC-HEART-DISEASE IN WOMEN THAN IN MEN - THE RANCHO-BERNARDO STUDY
    BARRETTCONNOR, EL
    COHN, BA
    WINGARD, DL
    EDELSTEIN, SL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (05): : 627 - 631
  • [3] VALIDITY OF CARDIOVASCULAR-DISEASE RISK-FACTORS ASSESSED BY TELEPHONE SURVEY - THE BEHAVIORAL RISK FACTOR SURVEY
    BOWLIN, SJ
    MORRILL, BD
    NAFZIGER, AN
    JENKINS, PL
    LEWIS, C
    PEARSON, TA
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (06) : 561 - 571
  • [4] Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities
    Braunwald, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) : 1360 - 1369
  • [5] USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY
    CALIFF, RM
    SHADOFF, N
    VALETT, N
    BATES, E
    GALEANA, A
    KNOPF, W
    SHAFTEL, J
    BENDER, MJ
    AVERSANO, T
    RAQUENO, J
    GURBEL, P
    COWFER, J
    COHEN, M
    CROSS, P
    BITTL, J
    EDDINGS, K
    TAYLOR, M
    DEROSA, K
    HATTEL, L
    COOPER, L
    ESHELMAN, B
    FINTEL, D
    NIEMYSKI, P
    KLEIN, L
    KENNEDY, H
    THORNTON, T
    KEREIAKES, D
    MARTIN, L
    ANDERSON, L
    HIGBY, N
    ELLIS, S
    BREZINA, K
    GEORGE, B
    CHAPEKIS, A
    SMITH, D
    ANWAR, A
    GERBER, TL
    PRITCHARD, GL
    MYLER, R
    SHAW, R
    MURPHY, M
    WARD, K
    MADIGAN, NP
    BLANKENSHIP, J
    HALBERT, M
    FLANAGAN, C
    TANNENBAUM, M
    POLICH, M
    STEVENSON, C
    TCHENG, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) : 956 - 961
  • [6] Centers for Disease Control and Prevention, 2000, BEH RISK FACT SURV S
  • [7] BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT
    COLLINS, R
    PETO, R
    MACMAHON, S
    HEBERT, P
    FIEBACH, NH
    EBERLEIN, KA
    GODWIN, J
    QIZILBASH, N
    TAYLOR, JO
    HENNEKENS, CH
    [J]. LANCET, 1990, 335 (8693) : 827 - 838
  • [8] Risk factors for popliteal and carotid wall thicknesses in the Atherosclerosis Risk in Communities (ARIC) Study
    Dobs, AS
    Nieto, FJ
    Szklo, M
    Barnes, R
    Sharrett, AR
    Ko, WJ
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1999, 150 (10) : 1055 - 1067
  • [9] Cholesterol reduction and clinical benefit - Are there limits to our expectations
    Fager, G
    Wiklund, O
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (12) : 3527 - 3533
  • [10] Type 2 diabetes in older well-functioning people: Who is undiagnosed? Data from the Health, Aging, and Body Composition Study
    Franse, LV
    Di Bari, M
    Shorr, RI
    Resnick, HE
    van Eijk, JTM
    Bauer, DC
    Newman, AB
    Pahor, M
    [J]. DIABETES CARE, 2001, 24 (12) : 2065 - 2070